NZ260408A
(en)
|
1993-05-10 |
1996-05-28 |
Euro Celtique Sa |
Controlled release preparation comprising tramadol
|
EP1009387B1
(fr)
*
|
1997-07-02 |
2006-04-12 |
Euro-Celtique S.A. |
Formulations de tramadol stabilisees a liberation prolongee
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
ES2264226T3
(es)
|
1997-12-22 |
2006-12-16 |
Euro-Celtique S.A. |
Forma farmaceutica de dosificacion oral que comprende una combinacion de un agonista opioide y naltrexona.
|
DE19901683B4
(de)
*
|
1999-01-18 |
2005-07-21 |
Grünenthal GmbH |
Analgetikum mit kontrollierter Wirkstofffreisetzung
|
AU781058B2
(en)
*
|
1999-08-31 |
2005-05-05 |
Grunenthal Gmbh |
Delayed-action form of administration containing tramadol saccharinate
|
PT1255547E
(pt)
|
2000-02-08 |
2008-11-24 |
Euro Celtique Sa |
Composições de libertação controlada contendo agonistas e antagonistas opióides
|
JP4570725B2
(ja)
*
|
2000-04-05 |
2010-10-27 |
大塚製薬株式会社 |
医薬製剤用組成物
|
WO2002092060A1
(fr)
|
2001-05-11 |
2002-11-21 |
Endo Pharmaceuticals, Inc. |
Forme posologique d'opioides a liberation prolongee empechant la consommation abusive
|
JP4310605B2
(ja)
|
2001-05-25 |
2009-08-12 |
大塚製薬株式会社 |
医薬用組成物
|
WO2002100382A2
(fr)
*
|
2001-06-08 |
2002-12-19 |
Endo Pharmaceuticals, Inc. |
Formes posologiques a liberation controlee utilisant un polymere acrylique, et leur procede d'obtention
|
US8329216B2
(en)
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
ES2284888T3
(es)
|
2001-07-06 |
2007-11-16 |
Endo Pharmaceuticals Inc. |
Administracion oral de 6-hidroxi-oximorfona utilizada como analgesico.
|
PT1416842E
(pt)
|
2001-07-18 |
2009-03-31 |
Euro Celtique Sa |
Composições farmacêuticas de oxicodona e naloxona
|
US20030157168A1
(en)
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
NZ530971A
(en)
|
2001-08-06 |
2004-08-27 |
Euro Celtique S |
Oral dosage forms comprising an opioid agonist with releasable and sequestered opioid antagonists
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
ATE367172T1
(de)
*
|
2001-11-08 |
2007-08-15 |
Atrium Medical Corp |
Intraluminale vorrichtung mit einer ein therapeutisches-mittel enthaltenden beschichtung
|
US8128957B1
(en)
|
2002-02-21 |
2012-03-06 |
Valeant International (Barbados) Srl |
Modified release compositions of at least one form of tramadol
|
JP4704685B2
(ja)
*
|
2002-02-21 |
2011-06-15 |
バイオヴェイル ラボラトリーズ インターナショナル エスアールエル |
徐放性製剤
|
US20050182056A9
(en)
*
|
2002-02-21 |
2005-08-18 |
Seth Pawan |
Modified release formulations of at least one form of tramadol
|
US8323692B2
(en)
|
2002-02-21 |
2012-12-04 |
Valeant International Bermuda |
Controlled release dosage forms
|
EP1490036A1
(fr)
*
|
2002-03-22 |
2004-12-29 |
Cilag AG |
Formule de tramadol a liberation prolongee
|
US20050245556A1
(en)
|
2002-04-05 |
2005-11-03 |
Bianca Brogmann |
Pharmaceutical preparation containing oxycodone and naloxone
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
US10004729B2
(en)
|
2002-07-05 |
2018-06-26 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
MY142204A
(en)
|
2002-07-25 |
2010-10-29 |
Pharmacia Corp |
Pramipexole once-daily dosage form
|
WO2004026256A2
(fr)
*
|
2002-09-20 |
2004-04-01 |
Alpharma, Inc. |
Preparations d'opioides a liberation soutenue et methodes d'utilisation
|
EP2422773A3
(fr)
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Séquestration de sous-unité et compositions et procédés associés
|
JP2006507276A
(ja)
*
|
2002-10-25 |
2006-03-02 |
ラボファーマ インコーポレイテッド |
放出制御組成物
|
CN1942175B
(zh)
*
|
2002-10-25 |
2010-05-26 |
莱博法姆公司 |
24小时有效的曲马多缓释制剂
|
RU2328275C2
(ru)
*
|
2002-10-25 |
2008-07-10 |
Лабофарм Инк. |
Композиции трамадола пролонгированного высвобождения с 24-часовым действием
|
US8487002B2
(en)
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
TWI319713B
(en)
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
DE10300325A1
(de)
|
2003-01-09 |
2004-07-22 |
Hexal Ag |
Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
|
US20060153915A1
(en)
*
|
2003-01-23 |
2006-07-13 |
Amorepacific Corporation |
Sustained-release preparations and method for producing the same
|
US7413749B2
(en)
*
|
2003-03-11 |
2008-08-19 |
Purdue Pharma L.P. |
Titration dosing regimen for controlled release tramadol
|
EP1905435A3
(fr)
|
2003-03-11 |
2008-05-14 |
Euro-Celtique S.A. |
Régime de dosage de titrage pour tramadol à libération contrôlée
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
TWI347201B
(en)
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
ES2289542T3
(es)
|
2003-08-06 |
2008-02-01 |
Grunenthal Gmbh |
Forma farmaceutica protegida contra un posible abuso.
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
GB0501638D0
(en)
*
|
2005-01-28 |
2005-03-02 |
Euro Celtique Sa |
Particulates
|
EP1604667A1
(fr)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioides pour le traitement des impatiences des membres inférieurs
|
EP1604666A1
(fr)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioides pour le traitement de la bronchopneumopathie chronique obstructive
|
WO2005123039A1
(fr)
|
2004-06-12 |
2005-12-29 |
Collegium Pharmaceutical, Inc. |
Formulations de prevention des abus
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
US20070224281A1
(en)
*
|
2004-07-22 |
2007-09-27 |
Amorepacific Corporation |
Sustained-Release Preparations Containing Topiramate and the Producing Method Thereof
|
BRPI0513846A
(pt)
|
2004-08-13 |
2008-05-20 |
Boehringer Ingelheim Int |
formulação de comprimido de liberação prolongada contendo pramipexol ou um sal farmaceuticamente aceitável do mesmo, método para a fabricação do mesmo e o uso do mesmo
|
EP2431026A1
(fr)
*
|
2004-08-13 |
2012-03-21 |
Boehringer Ingelheim International GmbH |
Formulation de pastille à libération prolongée contenant du pramipexole ou l'un de ses sels pharmaceutiquement acceptable, son procédé de fabrication et utilisation associée
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
WO2006037080A2
(fr)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Gel seche sous ultraviolet et procede de production correspondant
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
AU2006208627B8
(en)
*
|
2005-01-28 |
2009-08-13 |
Mundipharma Pty Limited |
Alcohol resistant dosage forms
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
EP1702558A1
(fr)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Procédé et dispositif pour évaluer la fonction de l'activité intestinale
|
EP1695700A1
(fr)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Forme posologique contenant de l'oxycodone et de la naloxone
|
EP2474308A1
(fr)
|
2005-06-27 |
2012-07-11 |
Valeant International (Barbados) SRL |
Formulations pharmaceutiques contenant l'hydrobromure de bupropion
|
US8221792B2
(en)
|
2005-07-07 |
2012-07-17 |
Farnam Companies, Inc. |
Sustained release pharmaceutical compositions for highly water soluble drugs
|
UA91376C2
(ru)
*
|
2005-08-24 |
2010-07-26 |
Рубикон Рисеч Пвт Лтд. |
Рецептура с контролируемым высвобождением
|
DK1931346T3
(da)
|
2005-09-09 |
2012-10-22 |
Angelini Labopharm Llc |
Trazodonsammensætning til indgivelse en gang om dagen
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
CN1957909B
(zh)
*
|
2005-10-31 |
2013-09-11 |
阿尔扎公司 |
降低***样物质持续释放口服剂型的由醇诱导的剂量突然释放的方法
|
GB2431875A
(en)
*
|
2005-10-31 |
2007-05-09 |
Alza Corp |
Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
LT1993559T
(lt)
|
2006-02-03 |
2016-11-10 |
Opko Renal, Llc |
Vitamino d nepakankamumo ir deficito gydymas su 25-hidroksivitaminu d2 ir 25-hidroksivitaminu d3
|
US20070190141A1
(en)
*
|
2006-02-16 |
2007-08-16 |
Aaron Dely |
Extended release opiate composition
|
PT2719378T
(pt)
|
2006-06-19 |
2016-11-02 |
Alpharma Pharmaceuticals Llc |
Composições farmacêuticas
|
CA2655499C
(fr)
|
2006-06-21 |
2015-10-27 |
Proventiv Therapeutics, Llc |
Methode de traitement et de prevention de l'hyperparathyroidie secondaire au moyen de therapies de repletion de vitamine d et de remplacement devitamine d
|
MX2008015996A
(es)
*
|
2006-06-23 |
2009-01-20 |
Esteve Labor Dr |
Combinacion de un inhibidor de la colinesterasa y un compuesto con afinidad por el receptor 5-ht6.
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
US11752158B2
(en)
|
2007-04-25 |
2023-09-12 |
Eirgen Pharma Ltd. |
Method of treating vitamin D insufficiency and deficiency
|
JP5501956B2
(ja)
|
2007-04-25 |
2014-05-28 |
シトクロマ インコーポレイテッド |
ビタミンd化合物およびワックス状担体を含有する制御放出性経口組成物
|
US20080318994A1
(en)
|
2007-06-21 |
2008-12-25 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US8383152B2
(en)
|
2008-01-25 |
2013-02-26 |
Gruenenthal Gmbh |
Pharmaceutical dosage form
|
US20090246276A1
(en)
|
2008-01-28 |
2009-10-01 |
Graham Jackson |
Pharmaceutical Compositions
|
SI2273983T1
(sl)
|
2008-05-09 |
2016-11-30 |
Gruenenthal Gmbh |
Postopek za pripravo intermediatne praškaste formulacije in končne trdne odmerne oblike z uporabo stopnje strjevanja z razprševanjem
|
US20100003322A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Lai Felix S |
Enteric coated hydrophobic matrix formulation
|
EP2448406B1
(fr)
|
2009-02-26 |
2016-04-20 |
Relmada Therapeutics, Inc. |
Compositions pharmaceutiques orales à libération prolongée de 3-hydroxy-n-méthylmorphinane et procédé d'utilisation
|
KR20140141727A
(ko)
|
2009-03-10 |
2014-12-10 |
유로-셀티큐 에스.에이. |
옥시코돈 및 날록손을 포함하는 즉시 방출 제약 조성물
|
TW201105316A
(en)
|
2009-07-22 |
2011-02-16 |
Gruenenthal Gmbh |
Hot-melt extruded pharmaceutical dosage form
|
AU2010275755B2
(en)
|
2009-07-22 |
2014-04-24 |
Grünenthal GmbH |
Oxidation-stabilized tamper-resistant dosage form
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
CN102821757B
(zh)
|
2010-02-03 |
2016-01-20 |
格吕伦塔尔有限公司 |
通过挤出机制备粉末状药物组合物
|
EP2544667B1
(fr)
*
|
2010-03-09 |
2018-11-14 |
Alkermes Pharma Ireland Limited |
Compositions pharmaceutiques entériques résistantes aux alcools
|
PT2552484T
(pt)
|
2010-03-29 |
2020-04-03 |
Opko Ireland Global Holdings Ltd |
Métodos e composições para redução dos níveis de parafróides
|
BR112012028788A2
(pt)
*
|
2010-05-10 |
2016-07-19 |
Euro Celtique Sa |
fabricação de grânulos sem ativos
|
US9700508B2
(en)
|
2010-05-10 |
2017-07-11 |
Euro-Celtique S.A. |
Pharmaceutical compositions comprising hydromorphone and naloxone
|
WO2011141490A1
(fr)
*
|
2010-05-10 |
2011-11-17 |
Euro-Celtique S.A. |
Combinaison de granules chargés de principe actif et de principes actifs supplémentaires
|
WO2012009707A2
(fr)
|
2010-07-16 |
2012-01-19 |
Atrium Medical Corporation |
Composition et procédés destinés à modifier la vitesse d'hydrolyse de substances vulcanisées à base d'huile
|
MX2013002377A
(es)
|
2010-09-02 |
2013-04-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
|
CN103179954A
(zh)
|
2010-09-02 |
2013-06-26 |
格吕伦塔尔有限公司 |
包含阴离子聚合物的抗破碎剂型
|
US10201502B2
(en)
|
2011-07-29 |
2019-02-12 |
Gruenenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
RS56527B1
(sr)
|
2011-07-29 |
2018-02-28 |
Gruenenthal Gmbh |
Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
|
MX356421B
(es)
|
2012-02-28 |
2018-05-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
|
EA201401139A1
(ru)
|
2012-04-18 |
2015-03-31 |
Грюненталь Гмбх |
Устойчивая к разрушению и к сбросу дозы фармацевтическая лекарственная форма
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 d 방출 제형
|
BR112015026549A2
(pt)
|
2013-05-29 |
2017-07-25 |
Gruenenthal Gmbh |
forma de dosagem à prova de violação contendo uma ou mais partículas
|
CA2913209A1
(fr)
|
2013-05-29 |
2014-12-04 |
Grunenthal Gmbh |
Forme dosifiee inviolable a profil de liberation bimodale
|
CA2917136C
(fr)
|
2013-07-12 |
2022-05-31 |
Grunenthal Gmbh |
Forme posologique inviolable contenant un polymere d'ethylene-acetate de vinyle
|
JP2016525138A
(ja)
|
2013-07-23 |
2016-08-22 |
ユーロ−セルティーク エス.エイ. |
疼痛および腸内ディスバイオシスをもたらす疾患および/または腸内細菌移行に対するリスクを高める疾患に罹患している患者における痛みの治療への使用のためのオキシコドンおよびナロキソンの組み合わせ
|
WO2015037019A2
(fr)
*
|
2013-09-15 |
2015-03-19 |
Rubicon Research Private Limited |
Formulations pharmaceutiques à libération modifiée
|
EP3068397A1
(fr)
|
2013-11-13 |
2016-09-21 |
Euro-Celtique S.A. |
Hydromorphone et naloxone utilisées pour le traitement de la douleur et du syndrome de dysfonctionnement intestinal dû aux opioïdes
|
WO2015078891A1
(fr)
|
2013-11-26 |
2015-06-04 |
Farmaceutici Formenti S.P.A. |
Préparation de composition pharmaceutique en poudre par cryo-broyage
|
WO2015173195A1
(fr)
|
2014-05-12 |
2015-11-19 |
Grünenthal GmbH |
Formulation pour capsule à libération immédiate résistant aux manipulations illicites comprenant du tapentadol
|
MX2016015417A
(es)
|
2014-05-26 |
2017-02-22 |
Gruenenthal Gmbh |
Multiparticulas protegidas contra vertido de dosis etanolico.
|
CA2957240A1
(fr)
|
2014-08-07 |
2016-02-11 |
Opko Ireland Global Holdings, Ltd. |
Therapie d'appoint avec de la 25-hydroxyvitamine d
|
EP3285745A1
(fr)
|
2015-04-24 |
2018-02-28 |
Grünenthal GmbH |
Forme galénique inviolable avec libération immédiate et résistance à l'extraction par solvant.
|
FR3037789A1
(fr)
*
|
2015-06-23 |
2016-12-30 |
Rondol Ind |
Ligne de production pour la production de medicaments, et installation de production comprenant une telle ligne de production
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
KR20230054752A
(ko)
|
2016-03-28 |
2023-04-25 |
옵코 아일랜드 글로벌 홀딩스 리미티드 |
비타민 d 치료 방법
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
WO2019087084A1
(fr)
|
2017-11-02 |
2019-05-09 |
Eman Biodiscoveries Sd. Bhd. |
Extrait d'orthosiphon stamineus, formulations et leurs utilisations
|
CA3112038A1
(fr)
*
|
2018-09-07 |
2020-03-12 |
R.P. Scherer Technologies, Llc |
Stabilisation de forme posologique a base de lipide solide ou semi-solide par durcissement et ajout de tensioactif(s) a faible hlb
|